Fibrinogen for the management of critical obstetric hemorrhage
- PMID: 30155944
- PMCID: PMC6585962
- DOI: 10.1111/jog.13788
Fibrinogen for the management of critical obstetric hemorrhage
Abstract
Aim: In cases of critical obstetric hemorrhage leading to extreme hypofibrinogenemia, fibrinogen is the marker that indicates the critical severity, and early fibrinogen supplementation centering on hemostatic resuscitation is a vital treatment to stabilize a catastrophic condition. In this review, we investigated the effect of fibrinogen level on hemostasis and what we can do to treat hypofibrinogenemia efficiently and improve patients' outcome.
Methods: We reviewed numerous articles related to hypofibrinogenemia in critical obstetric hemorrhage. Especially, we performed a systematic review on target value of fibrinogen for hemostasis and effectiveness of fibrinogen concentrate. We also reviewed the articles about the methods for early normalization of fibrinogen level such as tranexamic acid, massive transfusion protocol, and point-of-care testing.
Results: The target value of fibrinogen calculated by needs for massive transfusion was 200 mg/dL or 10 mm of A5FIBTEM . Although fibrinogen concentrate worked poorly on fibrinogen levels within the normal range, it improved the blood fibrinogen levels rapidly when it was administered to critical obstetric hemorrhage patients with serious hypofibrinogenemia. Hence, the volume of FFP transfused could be reduced along with a reduction in the frequency of pulmonary edema due to volume overload.
Conclusion: The patient group for which fibrinogen concentrate works most effectively is cases with severe hypofibrinogenemia. Further research is required in the light of evidence. The essence of the transfusion algorithm in critical obstetric hemorrhage is to approach the target value for obtaining hemostasis, ensure an accurate and prompt grasp of the severity using point-of-care testing, introduce a massive transfusion protocol and use tranexamic acid.
Keywords: coagulopathy; critical obstetrical hemorrhage; disseminated intravascular coagulation; fibrinogen; fibrinogen concentrate; fresh frozen plasma.
© 2018 The Authors. Journal of Obstetrics and Gynaecology Research published by John Wiley & Sons Australia, Ltd on behalf of Japan Society of Obstetrics and Gynecology.
Figures
References
-
- Japan Association of Obstetricians and Gynecologists . Japanese Maternal Death Registration Investigated by Japan Association of Obstetricians and Gynecologists, 2010‐2012. 2013. http://www.jaog.or.jp/wp/wp-content/uploads/2017/01/botai_2013.pdf Accessed Aug 12 2018.
-
- Cerneca F, Ricci G, Simeone R, Malisano M, Alberico S, Guaschino S. Coagulation and fibrinolysis changes in normal pregnancy. Increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis. Eur J Obstet Gynecol Reprod Biol 1997; 73: 31–36. - PubMed
-
- Rath WH. Postpartum hemorrhage – update on problems of definitions and diagnosis. Acta Obstet Gynecol Scand 2011; 90: 421–428. - PubMed
-
- Takeda S, Makino S, Takeda J et al Japanese clinical practice guide for critical obstetrical hemorrhage (2017 revision). J Obstet Gynaecol Res 2017; 43: 1517–1521. - PubMed
-
- Era S, Matsunaga S, Matsumura H, Murayama Y, Takai Y, Seki H. Usefulness of shock indicators for determining the need for blood transfusion after massive obstetric hemorrhage. J Obstet Gynaecol Res 2014; 41: 39–43. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
